A 42-year-old woman from Delhi is found to be HBsAg positive on routine screening during blood donation. She is asymptomatic with normal liver function tests (ALT 35 IU/L, AST 32 IU/L). Further serological testing shows: HBsAg positive, anti-HBs negative, anti-HBc positive (IgG), HBeAg negative, anti-HBe positive, HBV DNA 2 × 10³ copies/mL. What is the most appropriate interpretation?

Explanation

## Interpretation of Chronic HBV Serology — HBeAg-Negative Phase ### Clinical Context Asymptomatic patient with incidental HBsAg positivity and normal liver enzymes — consistent with chronic HBV infection in the low replicative phase. ### Serological Marker Interpretation | Marker | Result | Significance | |--------|--------|-------------| | HBsAg | Positive | Chronic infection (present >6 months) | | Anti-HBc IgG | Positive | Past/ongoing infection (not acute) | | Anti-HBc IgM | Negative | Rules out acute infection | | HBeAg | Negative | Low/no viral replication | | Anti-HBe | Positive | Seroconversion from HBeAg phase | | HBV DNA | 2 × 10³ copies/mL | Low viral load (<10⁵ copies/mL = low replicative) | **Key Point:** The absence of anti-HBc IgM and presence of anti-HBc IgG indicates chronic (not acute) infection. HBeAg negativity with anti-HBe positivity and low HBV DNA defines the **low replicative phase** of chronic HBV. ### Natural History of Chronic HBV ```mermaid flowchart TD A[Acute HBV Infection]:::outcome --> B{Recovery?}:::decision B -->|Yes 95%| C[Clearance + Anti-HBs]:::action B -->|No 5%| D[Chronic HBV]:::action D --> E[HBeAg-Positive Phase]:::outcome E -->|Seroconversion| F[HBeAg-Negative Phase]:::outcome E -->|High ALT| G[Active hepatitis, risk of cirrhosis]:::urgent F -->|Low HBV DNA| H[Low replicative phase, better prognosis]:::action F -->|Flares possible| I[Periodic ALT elevation, HBV DNA spikes]:::outcome ``` **High-Yield:** Chronic HBV has two main phases: 1. **HBeAg-positive phase:** High viral replication (HBV DNA >10⁵ copies/mL), higher risk of progression 2. **HBeAg-negative phase:** Low viral replication (HBV DNA <10⁵ copies/mL), better prognosis but still infectious **Clinical Pearl:** HBeAg-negative chronic HBV can still progress to cirrhosis and HCC, especially if HBV DNA remains detectable or if periodic flares occur. Regular monitoring (6–12 monthly ALT, HBV DNA, ultrasound) is essential. ### Why This Is Chronic, Not Acute - **Anti-HBc IgM negative:** Rules out acute infection - **Anti-HBc IgG positive:** Indicates established infection - **Asymptomatic, normal LFTs:** Consistent with low replicative phase - **HBeAg-negative, anti-HBe positive:** Seroconversion has occurred (typical after years of HBeAg-positive phase) **Mnemonic:** **HBeAg-NEG phase = NEGative HBeAg + Positive anti-HBe + LOW HBV DNA + Better prognosis (but still infectious)**